- AuthorisedTherapeutic exploratory (Phase II)
An open-label, non-randomized, single dose, phase II trial of FG001 (an optical imaging agent) for localization of Meningiomas or presumed Low- Grade Gliomas scheduled for neurosurgery.
Doctors are testing a new special dye called FG001 to help them see brain tumours like meningiomas and low-grade gliomas better during surgery. This study checks if the dye helps spot all the tumour tissue accurately and if it's safe for patients.
For: Glioma, MeningiomaDenmark - AuthorisedTherapeutic exploratory (Phase II)
An open-label, non-randomized, single center, single dose, exploratory phase II trial of FG001 (an imaging agent) in combination with transoral robotic surgery for oropharyngeal squamous cell carcinoma and neck dissection surgery for oral squamous cell carcinoma with regional lymph node metastases
This study looks at a special dye called FG001 to help surgeons find cancer better during operations for mouth and throat cancer. It aims to see if the dye can light up cancer cells, making them easier to remove completely.
For: Oral Squamous Cell Carcinoma with neck metastases, Oropharyngeal Squamous Cell CarcinomaDenmark